Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Treatment and Management of Acinetobacter Pneumonia: Lessons Learned from Recent World Event
Karyne Rangel, Salvatore G. De-Simone
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 507-529
Open Access | Times Cited: 10
Pathological Characteristics and Risk Factors of Secondary Pulmonary Infections Following COVID-19 Infection
昊楠 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 696-703
Closed Access
Impact of COVID-19 on healthcare-associated infections: Antimicrobial consumption does not follow antimicrobial resistance
Maristela Pinheiro Freire, Denise Brandão de Assis, Bruno de Melo Tavares, et al.
Clinics (2023) Vol. 78, pp. 100231-100231
Open Access | Times Cited: 11
A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic
Karri A. Bauer, Laura Puzniak, Kalvin Yu, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 16
eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy
Felipe Francisco Tuon, Tiago Zequinão, Marcelo Silva da Silva, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 4, pp. 707-723
Open Access | Times Cited: 3
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
Huan-Yi Wu, Peng-Hao Chang, Yu‐Shan Huang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 2, pp. 207-235
Open Access | Times Cited: 14
Antibiotic Resistance Patterns and Association With the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Associations Between Influenza Season and Resistance in Gram-Negative Pathogens
Vikas Gupta, Kalvin Yu, Heidi Kabler, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 8
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?
Adrian Brink, Guy A. Richards, Hafsah Deepa Tootla, et al.
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 6, pp. 595-604
Closed Access | Times Cited: 8
eHealth and mHealth in Antimicrobial Stewardship
Felipe Francisco Tuon, Tiago Zequinão, Marcelo Silva da Silva, et al.
(2024)
Open Access | Times Cited: 1
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
Karri A. Bauer, Laura Puzniak, Kalvin Yu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves
Laura Puzniak, Karri A. Bauer, Kalvin Yu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Antimicrobial Stewardship: Leveraging the “Butterfly Effect” of Hand Hygiene
Adrian Brink, Guy A. Richards
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1348-1348
Open Access | Times Cited: 3
Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis
Todd Riccobene, Gang Ye, John Lock, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa
Thomas P. Lodise, N Engels, Alexandre H. Watanabe, et al.
Journal of Antimicrobial Chemotherapy (2024)
Open Access
Whole Genome Sequencing, Characterization and Comparative Genome Analysis of Acinetobacter baumannii JJAB01: A Comprehensive Insights on Antimicrobial Resistance and Virulence Genotype
Raji Rajmichael, Nagarajan Hemavathy, Ahila Mathimaran, et al.
Microbial Pathogenesis (2024), pp. 107224-107224
Closed Access
The length-of-stay associated with adequacy of empirical antimicrobial therapy – systematic reviews with meta-analysis
Fernando Merlos, Felipe Francisco Tuon
Research Square (Research Square) (2024)
Closed Access
Molecular Typing and Resistance Profile of Acinetobacter baumannii Isolates during the COVID-19 Pandemic: Findings from the “EPIRADIOCLINF” Project
Antonella Agodi, Arturo Montineri, Rosa Manuele, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1551-1551
Open Access | Times Cited: 1
To Prescribe, or Not to Prescribe, That Is the Question
Chin Kook Rhee
Journal of Korean Medical Science (2022) Vol. 37, Iss. 29
Open Access | Times Cited: 1
Association of SARS-CoV-2 status and antimicrobial-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
Karri A. Bauer, Laura Puzniak, Kalvin Yu, et al.
Research Square (Research Square) (2023)
Open Access
Acinetobacter baumannii during COVID-19: What Is the Real Pandemic?
Karyne Rangel, Salvatore G. De-Simone
Pathogens (2022) Vol. 12, Iss. 1, pp. 41-41
Open Access
Page 1

Scroll to top